Jim Kean, CEO of Molecular is a seasoned tech executive who has always had a passion for innovative, consumer-oriented health and wellness digital experiences, He is at the forefront of AI's impact on healthcare and joins me to share the remarkable fusion of technology and medicine, a fusion that has the potential to not just treat ailments, but to foresee and prevent them. In this episode, we explore how AI is paving the way for predictive healthcare, the ethical considerations it brings, and the collaborative approach that's key to fully harnessing its potential. This is an eye-opening insight into AI and the healthcare revolution through its ability to process mass amounts of data, predict health risks on both an individual and global scale, and support doctors in individualising health care. Listen to the full podcast here: https://omny.fm/shows/ageless-by-rescu/jim-kean-ceo-molecular-youSee omnystudio.com/listener for privacy information.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
NPR News: 12-08-2025 2AM EST
08 Dec 2025
NPR News Now
NPR News: 12-07-2025 11PM EST
08 Dec 2025
NPR News Now
NPR News: 12-07-2025 10PM EST
08 Dec 2025
NPR News Now
Meidas Health: AAP President Strongly Pushes Back on Hepatitis B Vaccine Changes
08 Dec 2025
The MeidasTouch Podcast
Democrat Bobby Cole Discusses Race for Texas Governor
07 Dec 2025
The MeidasTouch Podcast
Fox News Crashes Out on Air Over Trump’s Rapid Fall
07 Dec 2025
The MeidasTouch Podcast